Unfavourable blood pressure and LDL-cholesterol levels in obese non-diabetic individuals

B H R Wolffenbuttel1, S N Slagter, R P van Waateringe

  • 1Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Insights

Obese individuals, particularly younger men, have higher blood pressure (BP) and LDL-cholesterol (LDL-C). Treatments improved but did not normalize BP, while statins reduced age-related LDL-C increases.

Area of Science:

  • Cardiovascular health
  • Obesity research
  • Public health

Background:

  • Early detection and management of hypertension and high cholesterol are crucial for cardiovascular risk reduction.
  • This study investigates differences in blood pressure (BP) and LDL-cholesterol (LDL-C) between obese and normal-weight individuals.

Purpose of the Study:

  • To compare BP and LDL-C levels in obese versus normal weight and overweight individuals.
  • To evaluate the quality of treatment for hypertension and high cholesterol across different BMI categories.

Main Methods:

  • Analysis of 87,648 participants from the Lifelines study, categorized by obesity status and age.
  • Calculation of mean systolic BP and LDL-C based on treatment, BMI, age, and sex.

Main Results:

  • Obese individuals exhibited significantly higher BP across all ages compared to normal weight and overweight individuals, most notably in men under 50.
  • Despite medication, BP control was insufficient in 20-50% of participants.
  • Obese participants had higher LDL-C than normal-weight individuals, even with increased statin use; statins effectively mitigated age-related LDL-C increases.

Conclusions:

  • Obesity is linked to elevated BP and LDL-C, particularly in younger men.
  • BP-lowering drugs did not fully normalize BP to age and BMI-specific levels.
  • Increased attention to active screening and treatment of cardiovascular risk factors in obese populations is warranted.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
275
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
301
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
649
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
197
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
5.7K